Global phosphoproteome analysis of human bone marrow reveals predictive 
phosphorylation markers for the treatment of acute myeloid leukemia with 
quizartinib

Schaab, C.; Oppermann, F. S.; Klammer, M.; Pfeifer, H.; Tebbe, A.; Oellerich, T.; Krauter, J.; Levis, M.; Perl, A. E.; Daub, H.; Steffen, B.; Godl, K.; Serve, H.

doi:10.1038/leu.2013.347

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib

MPS-Authors

/persons/resource/persons78611

Schaab, C.
Mann, Matthias / Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

leu2013347a.pdf
(Any fulltext), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Schaab, C., Oppermann, F. S., Klammer, M., Pfeifer, H., Tebbe, A., Oellerich, T., et al. (2014). Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. LEUKEMIA, 28(3), 716-719. doi:10.1038/leu.2013.347.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0019-0EA5-6

Abstract

There is no abstract available